Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Finance

Results: 3157-3168 of 41643

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa) ▼

Court Authorizes Notice of Proposed Class Action Settlement for Farmers, Landscapers and Others Exposed to Weed Killers

PR Newswire associated0

Risen Energy's Low-Silver Strategy for HJT Technology: A Long-Term Roadmap

Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region

Business Wire logo

Kinaxis Announces Amendment to Maximize Size of Normal Course Issuer Bid

Business Wire logo

Dealings in Securities by Executive Directors of AngloGold Ashanti plc

Business Wire logo

Citi Issues Inaugural Digitally Native Structured Note on Euroclear's D-FMI DLT Platform

PR Newswire associated0

Women Are Powering the Next Wave of Global Travel, Says Trip.com Group

PR Newswire associated0

COSRX Presents Peptides, Snail Mucin and PDRN as Key Skincare Solutions for Amazon Spring Deal Days

From PolyU Research to Geneva Global Debut: GOOD Vision oka³y! ™ Redefines Precision in Freeform Orthokeratology

JDEnergy Showcases All-Scenario Energy Storage Solutions at KEY Energy 2026

Axiom Equity Announces Final Close of Second Flagship Fund Above Hard-Cap

  • Prev Page
  • 1
  • 2
  • …
  • 263
  • 264
  • 265
  • …
  • 3470
  • 3471
  • Next Page

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2026

Terms of Use

Privacy Policy

Contact Us